ADAPTIMMUNE Sample Clauses

ADAPTIMMUNE. (a) LTC, at its own expense, shall indemnify, defend and hold harmless ADAPTIMMUNE, and its AFFILIATES and their respective officers, directors, shareholders, employees and agents (each a “ADAPTIMMUNE INDEMNIFIED PARTY”), from and against any LIABILITIES incurred or imposed upon any and all ADAPTIMMUNE INDEMNIFIED PARTIES in connection with any THIRD PARTY CLAIMS arising out or in connection with *** in this SUB-LICENSE *** ; except in each case to the extent that such CLAIM arises out of or results from (a) the *** herein, or (b) *** .
Sample 1Sample 2Sample 3See All (5)
AutoNDA by SimpleDocs
ADAPTIMMUNE. Adaptimmune shall provide all its requested mutations and combinations of mutations within 14 days of written request from Immunocore. Pending receipt of such request, Immunocore will not file the Later Application or do anything which may jeopardise the filing, prosecution or maintenance of the Later Application.
Sample 1Sample 2
ADAPTIMMUNE. [***]. Adaptimmune will provide updates at JIPC meetings in relation to Patents within the Adaptimmune Platform IP, including those listed in Exhibit C (Adaptimmune Licensed Patent Rights) to the extent such Patents continue to Cover any Licensed Products or the Development of any Licensed Products. [***]. GNE will provide all reasonable cooperation and assistance to Adaptimmune at Adaptimmune’s reasonable request and at Adaptimmune’s expense in Prosecution and Maintenance of the Adaptimmune Prosecuted Patents, including making data, reports, and scientific personnel reasonably available to prepare and prosecute patent applications. [***].
Sample 1
ADAPTIMMUNE. LIMITED a company incorporated in the United Kingdom under number 06456741 whose registered office is at 91 Xxxxxx Xxxx, Abingdon, Xxxx XX00 0XX, Xxxxxx Xxxxxxx (“Adaptimmune”); and
Sample 1
ADAPTIMMUNE. Adaptimmune represents, warrants, and covenants to Universal Cells as of the Effective Date that:
Sample 1
ADAPTIMMUNE. LIMITED (Company number 6456741) whose registered office is at 60 Jubilee Avenue, Xxxxxx Xxxx, Abingdon, Xxxxxxxxxxx, Xxxxxxx XX00 0XX (Tenant);
Sample 1
ADAPTIMMUNE. Subject to Section 11.2.5 (Divisional Patent Rights), Adaptimmune will keep Galapagos reasonably and regularly informed of the status of the Prosecution and Maintenance of the Licensed Patent Rights other than the Other Collaboration Patent Rights (“Adaptimmune Prosecuted Patent Rights”), and will promptly provide Galapagos with copies of all material correspondence received from any patent authority in connection therewith. In addition, Adaptimmune will promptly provide Galapagos with drafts of all proposed material filings and material correspondence to any patent authority with respect to the Adaptimmune Prosecuted Patent Rights for Galapagos’ review and comment prior to the submission of such proposed filings or correspondence, and will reasonably consider Galapagos’ comments in good faith. Galapagos will provide all reasonable cooperation and assistance to Adaptimmune at Adaptimmune’s reasonable request and at Adaptimmune’s expense in Prosecution and Maintenance of the Adaptimmune Prosecuted Patent Rights, including making data, reports, and scientific personnel reasonably available to prepare and prosecute patent applications. If Adaptimmune elects not to Prosecute and Maintain any Adaptimmune Prosecuted Patent Rights (including by deciding not to file any patent application, other than in the case of choice of counties in relation to which any patent application is filed or perfected (after the filing of a priority or PCT or equivalent patent application) and providing that such country decision is taken in accordance with Adaptimmune’s normal patent prosecution processes), and such Adaptimmune Prosecuted Patent Right Covers any Licensed Product and such decision is not based on a desire to maintain the inventions set forth in such Patent Right as Confidential Information, then Adaptimmune will provide at least (***) days’ prior written notice to Galapagos. Thereafter, Galapagos will have the right, but not the obligation, to Prosecute and Maintain such Adaptimmune Prosecuted Patent Rights, at its sole expense and in its sole discretion, and Galapagos will have the right to elect to require transfer of ownership of rights of any such Adaptimmune Prosecuted Patent Right to Galapagos if that Adaptimmune Prosecuted Patent Right relates solely to Licensed Products (i.e., it Covers the Licensed Product and does not Cover any other products or TCR sequences or vectors for other TCR sequences), at Galapagos’ sole discretion and expense (“Galapagos Step-In ...
Sample 1
AutoNDA by SimpleDocs

Related to ADAPTIMMUNE

  • Licensee Licensee represents and warrants that:

  • Licensor any Person from whom a Grantor obtains the right to use any Intellectual Property. Lien: any Person’s interest in Property securing an obligation owed to, or a claim by, such Person, whether such interest is based on common law, statute or contract, including liens, security interests, pledges, hypothecations, statutory trusts, reservations, exceptions, encroachments, easements, rights-of-way, covenants, conditions, restrictions, leases, and other title exceptions and encumbrances affecting Property. Lien Waiver: an agreement, in form and substance satisfactory to Collateral Agent, by which (a) for any material Collateral located on leased premises, the lessor waives or subordinates any Lien it may have on the Collateral, and agrees to permit Collateral Agent to enter upon the premises and remove the Collateral or to use the premises to store or dispose of the Collateral; (b) for any Collateral held by a warehouseman, processor, shipper, customs broker or freight forwarder, such Person waives or subordinates any Lien it may have on the Collateral, agrees to hold any Documents in its possession relating to the Collateral as agent for Collateral Agent, and agrees to deliver the Collateral to Collateral Agent upon request; (c) for any Collateral held by a repairman, mechanic or bailee, such Person acknowledges Collateral Agent’s Lien, waives or subordinates any Lien it may have on the Collateral, and agrees to deliver the Collateral to Collateral Agent upon request; and (d) for any Collateral subject to a Licensor’s Intellectual Property rights, the Licensor grants to Collateral Agent the right, vis-à-vis such Licensor, to enforce Collateral Agent’s Liens with respect to the Collateral, including the right to dispose of it with the benefit of the Intellectual Property, whether or not a default exists under any applicable License.

  • Licensed Technology The term “Licensed Technology” shall mean the Licensed Patents and Licensed Know-How.

  • Collaboration We believe joint effort toward common goals achieves trust and produces greater impact for L.A. County’s youngest children and their families.

  • Third Party Technology The Company makes use of third party technology to collect information required for traffic measurement, research, and analytics. Use of third party technology entails data collection. We therefore would like to inform clients the Company enables third parties to place or read cookies located on the browsers of users entering the Company’s domain. Said third parties may also use web beacons to collect information through advertising located on the Company’s web site. Please note that you may change your browser settings to refuse or disable Local Shared Objects and similar technologies; however, by doing so you may be disabling some of the functionality of Company’s services.

Draft better contracts in just 5 minutes Get the weekly Law Insider newsletter packed with expert videos, webinars, ebooks, and more!